Insider · CIK 0001235862

POST LEONARD E

Reports to the SEC for 5 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001235862

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2026-10-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−500 sh	$61.65	−$30.8K	500
2026-10-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−500 sh	$62.48	−$31.2K	0
2026-10-15	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	102,077
2026-09-15	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2026-09-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$72.98	−$73K	0
2026-09-15	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	103,077
2026-08-14	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2026-08-14	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$74.54	−$74.5K	0
2026-08-14	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	104,077
2026-07-15	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2026-07-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$71.17	−$71.2K	0
2026-07-15	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	105,077
2026-06-24	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$0.60	+$3,000	5,000
2026-06-24	CGONCG Oncology, Inc.S Sale	Director	SSale	−5,000 sh	$70.00	−$350K	0
2026-06-24	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	106,077
2026-06-22	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$0.60	+$3,000	5,000
2026-06-22	CGONCG Oncology, Inc.S Sale	Director	SSale	−5,000 sh	$65.00	−$325K	0
2026-06-22	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	111,077
2026-06-11	QUREuniQure N.V.S Sale	Director	SSale	−1,993 sh	$27.06	−$53.9K	35,494
2026-06-10	QUREuniQure N.V.A Award	Director	AAward	+7,550 sh	—	—	37,487
2026-06-10	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	13,980
2026-06-04	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2026-06-04	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$54.50	−$54.5K	0
2026-06-04	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	116,077
2026-06-04	CGONCG Oncology, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+9,354 sh	—	—	9,354
2025-11-17	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2025-11-17	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$41.43	−$41.4K	0
2025-11-17	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	117,077
2025-10-13	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2025-10-13	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$43.25	−$43.3K	0
2025-10-13	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	118,077
2025-09-30	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$0.60	+$3,000	5,000
2025-09-30	CGONCG Oncology, Inc.S Sale	Director	SSale	−5,000 sh	$40.09	−$200K	0
2025-09-30	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	119,077
2025-09-15	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2025-09-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$35.10	−$35.1K	0
2025-09-15	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	124,077
2025-09-03	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2025-09-03	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$28.00	−$28K	0
2025-09-03	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	125,077
2025-07-17	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$0.60	+$1,200	2,000
2025-07-17	CGONCG Oncology, Inc.S Sale	Director	SSale	−2,000 sh	$28.00	−$56K	0
2025-07-17	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	126,077
2025-06-20	QUREuniQure N.V.S Sale	Director	SSale	−2,112 sh	$14.45	−$30.5K	29,937
2025-06-11	QUREuniQure N.V.A Award	Director	AAward	+7,970 sh	—	—	32,049
2025-06-11	QUREuniQure N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,630
2025-06-05	CGONCG Oncology, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+24.2K sh	—	—	24,165
2025-05-21	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$0.60	+$600	1,000
2025-05-21	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,000 sh	$28.00	−$28K	0

Recent filings

Accepted (ET)
Oct 194
POST LEONARD E0001193125-26-425295
SEC(opens sec.gov)
Sep 174
POST LEONARD E0001193125-26-394394
SEC(opens sec.gov)
Aug 184
POST LEONARD E0001193125-26-355561
SEC(opens sec.gov)
Jul 174
POST LEONARD E0001193125-26-307838
SEC(opens sec.gov)
Jun 254
POST LEONARD E0001193125-26-282861
SEC(opens sec.gov)
Jun 234
POST LEONARD E0001193125-26-279543
SEC(opens sec.gov)
Jun 124
POST LEONARD E0000904454-26-000344
SEC(opens sec.gov)

Companies

Address

C/O CG ONCOLOGY, INC. 3000 PEGASUS PARK DRIVE, SUITE 1640

DALLAS, TX, 75247